The role of vitamin D in human health: A paradigm shift

Journal of Evidence-Based Complementary and Alternative Medicine

Volumn 16, Issue 2, 2011, Pages 58-72

  Lappe, Joan M ^a  

^a CREIGHTON UNIVERSITY   (United States)

Author keywords

Cancer; Cardiovascular disease; Osteoporosis; Respiratory infections; Vitamin D

Indexed keywords

EID: 79957928871     PISSN: 21565872     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (195)

1. National Academy of Science. Dietary Reference Intakes for Calcium, Magnesium, Phosphorus, Vitamin D, and Fluoride. Washington, DC: National Academies Press; 1999.
2. Stumpf W, Sar M, DeLuca H. Sites of action of 1,25(OH)D2 identified by thaw-mount autoradiography. In: Cohn D, Talmage R, Matthews K, eds. Hormonal Control of Calcium Metabolism. Amsterdam, Netherlands: Oxford-Princeton; 1981:222-229.
3. Schwartz G, Whitlatch L, Chen T, Lokeshwar B, Holick M. Human prostate cells synthesize 1,25-dihydroxyvitamin D3 from 25-hydroxyvitamin D3. Cancer Epidemiol Biomarkers Prev. 1998;7:391-395.
4. Mawer E, Hayes M, Heys S. Constitutive synthesis of 1,25-dihydroxyvitamin D3 by a human small cell lung cancer cell line. J Clin Endocrinol Metab. 1994;79:554-560.
5. Cross H, Bareis P, Hofer H. 25-Hydroxyvitamin D3-1-alpha-hydroxlyase and vitamin D receptor gene expression in human colonic mucosa is elevated during early cancerogenesis. Steroids. 2001;66:287-292.
6. Tangpricha V, Flanagan J, Whitlatch L. 25-Hydroxyvitamin D-1-alpha-hydroxylase in normal and malignant colon tissue. Lancet. 2001;357:1673-1674.
7. Holick MF. High prevalence of vitamin D inadequacy and implications for health. Mayo Clin Proc. 2006;81:353-373.
8. Jones G. Metabolism and catabolism of vitamin D, its metabolites and clinically relevant analogs. In: Holick M, ed. Vitamin D: Physiology, Molecular Biology, and Clinical Applications. 2nd ed. Boston, MA: Humana Press; 2010:99-134.
9. Heaney RP. Functional indices of vitamin D status and ramifications of vitamin D deficiency. Am J Clin Nutr. 2004;80(suppl): 1706S-1709S.
10. Thomas M, Lloyd-Jones D, Thadhani R, et al. Hypovitami-nosis D in medical inpatients. N Engl J Med. 1998;338: 777-783.
11. Chapuy M, Prezoisi P, Maamer M. Prevalence of vitamin D insufficiency in an adult normal population. Osteoporos Int. 1997;7: 439-443.
12. Need A, O'Loughlin P, Morris H, Horowitz M, Nordin B. The effects of age and other variables on serum parathyroid hormone in postmenopausal women attending an osteoporosis center. J Clin Endocrinol Metab. 2004;89:1646-1649.
13. Holick M, Siris E, Binkley N, et al. Prevalence of vitamin D inadequacy among postmenopausal North American women receiving osteoporosis therapy. J Clin Endocrinol Metab. 2005; 90:3215-3224.
14. Lappe JM, Davies KM, Travers-Gustafson D, Heaney RP. Vitamin D status in a rural postmenopausal female population. J Am Clin Nutr. 2006;25:395-402.
15. Heaney RP, Dowell M, Hale C, Bendich A. Calcium absorption varies within the reference range for serum 25-hydroxyvitamin D. J Am Coll Nutr. 2003;22:142-146.
16. Barger-Lux J, Heaney R. Effects of above average summer sun exposure on serum 25-hydroxyvitamin D and calcium absorption fraction. J Clin Endocrinol Metab. 2002;87: 4952-4956.
17. Heaney RP. Vitamin D depletion and effective calcium absorption. J Bone Miner Res. 2003;18:1342.
18. Bischoff-Farrari H, Dietrich T, Orav E. Higher 25-hydroxy-vitamin D concentrations are associated with better lower-extremity function in both active and inactive persons aged over 60 y. Am J Clin Nutr. 2004;80:752-758.
19. Bischoff-Farrari H, Dietrich T, Orav EJ, Dawson-Hughes B. Positive association between 25-hydroxy vitamin D levels and bone mineral density; a population-based study of younger and older adults. Am J Med. 2004;116:634-639.
20. Grau M, Baron J, Sandler R, et al. Vitamin D, calcium supplementation, and colorectal adenomas: results of a randomized trial. J Natl Cancer Inst. 2003;95:1765-1771.
21. Platz E, Hankinson S, Hollis B. Plasma 1,25-dihydroxyvitamin D and adenomatous polyps of the distal colorectum. Cancer Epidemiol Biomarkers Prev. 2000;9:1059-1065.
22. Chiu KC, Chu A, Go VL, Saad MF. Hypovitaminosis D is associated with insulin resistance and beta cell dysfunction. Am J Clin Nutr. 2004;79:820-825.
23. Vieth R. Vitamin D supplementation, 25-hydroxyvitamin D concentrations, and safety. Am J Clin Nutr. 1999;69:842-856.
24. Binkley N, Novotny R, Krueger D, et al. Low vitamin D status despite abundant sun exposure. J Clin Endocrinol Metab. 2007; 92:2130-2135.
25. Garland C, Garland F, Gorham E, et al. The role of vitamin D in cancer prevention. Am J Public Health. 2006;96:252-261.
26. Yetley EA. Assessing the vitamin D status of the US population. Am J Clin Nutr. 2008;88:558S-564S.
27. Ginde AA, Liu MC, Camargo CA Jr. Demographic differences and trends of vitamin D insufficiency in the US population, 1988-2004. Arch Intern Med. 2009;169:626-632.
28. Greer FR. 25-Hydroxyvitamin D: functional outcomes in infants and young children. Am J Clin Nutr. 2008;88: 529S-533S.
29. Armas L, Heaney R, Barger-Lux J, Huerter C, Lund R. The effects of UV-B on serum 25(OH)D in humans with dark skin. J Bone Miner Res. 2006;21(suppl 1):S449.
30. Looker A, Pfeiffer C, Lacher D, Schleicher R, Picciano M, Yetley E. Serum 25-hydroxyvitamin D status of the US population: 1988-1994 compared with 2000-2004. Am J Clin Nutr. 2008;88:1519-1527.
31. Adams JS, Hewison M. Update in vitamin D. J Clin Endocrinol Metab. 2010;95:471-478.
32. Rohde CM, Manatt M, Clagett-Dame M, DeLuca HF. Vitamin A antagonizes the action of vitamin D in rats. J Nutr. 1999;129: 2246-2250.
33. Holick M. Vitamin D: the underappreciated D-lightful hormone that is important for skeletal and cellular health. Curr Opin Endo-crinol Diabetes. 2002;9:87-98.
34. Heaney RP, Davis KM, Chen T, Holick M, Barger-Lux J. Human serum 25-hydroxycholecalciferol response to extended oral dosing with cholecalciferol. Am J Clin Nutr. 2003;77:204-210.
35. Lappe JM, Davies KM, Travers-Gustafson D, Heaney RP. Vitamin D status in a rural postmenopausal female population. J Am Coll Nutr. 2006;25:395-402.
36. Harris S, Dawson-Hughes B. Seasonal changes in plasma 25-hydroxyvitamin D concentrations of young American black and white women. Am J Clin Nutr. 1998;67:1232-1236.
37. Dawson-Hughes B, Harris S, Dallal G. Plasma calcidiol, season, and serum parathyroid hormone concentrations in healthy elderly men and women. Am J Clin Nutr. 1997;65:67-71.
38. Armas L, Dowell S, Akhter M, et al. Ultraviolet-B radiation increases serum 25-hydroxyvitamin D levels: the effect of UVB dose and skin color. J Am Acad Dermatol. 2007;57: 588-593.
39. Matsuoka L, Ide L, Wortsman J. Sunscreens suppress cutaneous vitamin D3 synthesis. J Clin Endocrinol Metab. 1987;64: 1165-1168.
40. Wagner CL, Greer FR, Section on Breastfeeding and Committee on Nutrition. Prevention of rickets and vitamin D deficiency in infants, children, and adolescents. Pediatrics. 2008;122: 1142-1152.
41. Yetley EA, Brule D, Cheney MC, et al. Dietary reference intakes for vitamin D: justification for a review of the 1997 values. Am J Clin Nutr. 2009;89:719-727.
42. Bikle D. Nonclassic actions of vitamin D. J Clin Endocrinol Metab. 2009;94:26-34.
43. Armas LA, Hollis BW, Heaney RP. Vitamin D2 is much less effective than vitamin D3 in humans. J Clin Endocrinol Metab. 2004;89:5387-5391.
44. Trang H, Cole D, Rubin L, Pierratos A, Siu S, Vieth R. Evidence that vitamin D3 increases serum 25-hydroxyvitamin D more efficiently than does vitamin D2. Am J Clin Nutr. 1998;68:854-858.
45. Romagnoli E, Mascia ML, Cipriani C, et al. Short and long-term variations in serum calciotropic hormones after a single very large dose of ergocalciferol (vitamin D2) or cholecalciferol (vitamin D3) in the elderly. J Clin Endocrinol Metab. 2008;93:3015-3020.
46. Holick MF, Biancuzzo RM, Chen TC, et al. Vitamin D2 is as effective as vitamin D3 in maintaining circulating concentrations of 25-hydroxyvitamin D. J Clin Endocrinol Metab. 2008;93: 677-681.
47. Heaney RP, Barger-Lux J, Dowell MS, Chen T, Holick MF. Calcium absorptive effects of vitamin D and its major metabolites. J Clin Endocrinol Metab. 1997;82:4111-4116.
48. Heaney R. The vitamin D requirement in health and disease. J Steroid Biochem Mol Biol. 2005;97:13-19.
49. Binkley N, Krueger D, Lensmeyer G. 25-hydroxyvitamin D measurement, 2009: a review for clinicians. J Clin Densitom. 2009; 12:417-427.
50. Vieth R. Vitamin D toxicity, policy and science. J Bone Miner Res. 2007;22(suppl):V64-V68.
51. Tangpricha V, Turner A, Spina C, Decastro S, Chen T, Holick M. Tanning is associated with optimal vitamin D status (serum 25-hydroxyvitamin D concentration) and higher bone mineral density. Am J Clin Nutr. 2004;80:1645-1649.
52. Hathcock J, Shao A, Vieth R, Heaney R. Risk assessment for vitamin D. Am J Clin Nutr. 2007;85:6-18.
53. Giovannucci E, Platz EA. In: Feldman, D, Glorieux, Francis H, Pike, JW, eds. Epidemiology of Cancer Risk: Vitamin D and Calcium. 2nd ed. Boston, MA: Elsevier Inc; 2005:1617-1634.
54. Kennel K, Drake M, Hurley D. Vitamin D deficiency in adults: when to test and how to treat. Mayo Clin Proc. 2010;85:752-758.
55. Binkley N, Germar D, Engelke JA, Gangnon R, Ramamurthy R, Krueger D. Dosing with ergocalciferol or cholecalciferol, 1,600 IU daily or 50,000 IU monthly, is safe but does not assure vitamin D adequacy. J Bone Miner Res. 2009;24(suppl):24.
56. Wagner C, Johnson D, Hulsey T, et al. Vitamin D supplementation during pregnancy part 2 NICHD/CTSA Rand Trial (RCT): outcomes. Paper presented at: Pediatric Academic Societies' 2010 Annual Meeting; Vancouver, British Columbia, Canada; May 1-4, 2010.
57. Jones G. Pharmacokinetics of vitamin D toxicity. Am J Clin Nutr. 2008;88(suppl):582S-586S.
58. Heaney R. Nutrition and chronic disease. Mayo Clin Proc. 2006; 81:297-299.
59. Aaron J, Gallagher J, Anderson J, et al. Frequency of osteomala-cia and osteoporosis in fractures of the proximal femur. Lancet. 1974;1:229-233.
60. Bischoff-Farrari H, Willet W, Wong J, Giovannucci E, Dietrich T, Dawson-Hughes B. Fracture prevention with vitamin D supplementation. JAMA. 2005;293:2257-2264.
61. Tinetti ME, Speechley M, Ginter SF. Risk factors for falls among elderly persons living in the community. N Engl J Med. 2010;319: 1701-1707.
62. Bischoff-Ferrari HA, Borchers M, Gudat F, Durmuller U, Stahelin HB, Dick W. Vitamin D receptor expression in human muscle tissue decreases with age. J Bone Miner Res. 2004;19: 265-269.
63. Sorensen OH, Lund B, Saltin B, et al. Myopathy in bone loss of ageing: improvement by treatment with 1 alpha-hydroxycholecalciferol and calcium. Clin Sci (Lond). 1979;56: 157-161.
64. Bischoff-Ferrari HA, Dietrich T, Orav EJ, et al. Higher 25-hydroxyvitamin D concentrations are associated with better lower-extremity function in both active and inactive persons aged >60 y. Am J Clin Nutr. 2004;80:752-758.
65. Bischoff HA, Stahelin HB, Dick W, et al. Effects of vitamin D and calcium supplementation on falls: a randomized controlled trial. J Bone Miner Res. 2003;18:343-351.
66. Pfeifer M, Begerow B, Minne HW, Suppan K, Fahrleitner-Pammer A, Dobnig H. Effects of a long-term vitamin D and calcium supplementation on falls and parameters of muscle function in community-dwelling older individuals. Osteoporos Int. 2009;20:315-322.
67. Bischoff H, Stahelin HB, Dick W, et al. Effects of vitamin D and calcium supplements on falls: a randomized controlled trial. J Bone Miner Res. 2003;18:343-351.
68. Bischoff-Ferrari HA, Orav EJ, Dawson-Hughes B. Effect of cholecalciferol plus calcium on falling in ambulatory older men and women: a 3-year randomized controlled trial. Arch Intern Med. 2006;166:424-430.
69. Pfeifer M, Begerow B, Minne HW, Abrams C, Nachtigall D, Hansen C. Effects of a short-term vitamin D and calcium supplementation on body sway and secondary hyperparathyroidism in elderly women. J Bone Miner Res. 2000;15:1113-1118.
70. Broe KE, Chen TC, Weinberg J, Bischoff-Ferrari HA, Holick MF, Kiel DP. A higher dose of vitamin d reduces the risk of falls in nursing home residents: a randomized, multiple-dose study. J Am Geriatr Soc. 2007;55:234-239.
71. Peller S, Stephenson C. Skin irritation and cancer in the United States Navy. Am J Med. 1937;194:326-333.
72. Apperly F. The relation of solar radiation to cancer mortality in North America. Cancer Res. 1941;1:191-195.
73. Garland C, Garland F. Do sunlight and vitamin D reduce the likelihood of colon cancer? Int J Epidemiol. 1980;9:227-231.
74. Grant W. An estimate of premature cancer mortality in the U.S. due to inadequate doses of solar ultraviolet-B radiation. Cancer. 2002;94:1867-1875.
75. Holick MF. Vitamin D: its role in cancer prevention and treatment. Prog Biophys Mol Biol. 2006;92:49-59.
76. Giovannucci E. The epidemiology of vitamin D and cancer incidence and mortality: a review (United States). Cancer Causes Control. 2005;16:83-95.
77. Grant WB, Garland CF. The association of solar ultraviolet B (UVB) with reducing risk of cancer: multifactorial ecologic analysis of geographic variation in age-adjusted cancer mortality rates. Anticancer Res. 2006;26:2687-2699.
78. Pilz S, Dobnig H, Winklhofer-Roob B, et al. Low serum levels of 25-hydroxyvitamin D predict fatal cancer in patients referred to coronary angiography. Cancer Epidemiol Biomarkers Prev. 2008;17:1228-1233.
79. Feskanich D, Ma J, Fuchs CS, et al. Plasma vitamin D metabolites and risk of colorectal cancer in women. Cancer Epidemiol Biomarkers Prev. 2004;13:1502-1508.
80. Ahonen M, Tenkanen L, Teppo L. Prostate cancer risk and pre-diagnostic serum 25-hydroxyvitamin D levels (Finland). Cancer Causes Control. 2000;11:847-852.
81. Gorham ED, Garland CF, Garland FC, et al. Vitamin D and prevention of colorectal cancer. J Steroid Biochem Mol Biol. 2005; 97:179-194.
82. Abbas S, Linseisen J, Slanger T, et al. Serum 25-hydroxyvitamin D and risk of post-menopausal breast cancer-results of a large case-control study. Carcinogenesis. 2008;29:93-99.
83. Bertone-Johnson E, Chen W, Holick M, et al. Plasma 25-hydroxyvitamin D and 1,25-dihydroxyvitamin D and risk of breast cancer. Cancer Epidemiol Biomarkers Prev. 2005;14: 1991-1997.
84. Garland C, Garland F, Shaw E. Serum 25-hydroxyvitamin D and colon cancer: eight-year prospective study. Lancet. 1989;18: 1176-1178.
85. Cox AJ, Gleeson M, Pyne DB, Callister R, Hopkins WG, Fricker PA. Clinical and laboratory evaluation of upper respiratory symptoms in elite athletes. Clin J Sport Med. 2008;18: 438-445.
86. Tworoger S, Lee IM, Buring J, et al. Plasma 25-hydroxyvitamin D and 1,25-dihydroxyvitamin D and risk of incident ovarian cancer. Cancer Epidemiol Biomarkers Prev. 2007;16:783-788.
87. Teegarden D, Legowski P, Gunther C, McCabe G, Peacock M, Lyle R. Dietary calcium intake protects women consuming oral contraceptives from spine and hip bone loss. J Clin Endocrinol Metab. 2005;90:5127-5133.
88. Ahn J, Peters U, Albanes D, et al. Serum vitamin D concentration and prostate cancer risk: a nested case-control study. J Natl Cancer Inst. 2008;100:796-804.
89. Lappe JM, Travers Gustafson D, Davies KM, Recker RR, Heaney RP. Vitamin D and calcium supplementation reduces cancer risk: results of a randomized trial. Am J Clin Nutr. 2007;85:1586-1591.
90. Wactawski Wende J, Kotchen JM, Anderson GL, et al. Calcium plus vitamin D supplementation and the risk of colorectal cancer. N Engl J Med. 2006;354:684-696.
91. Ng K, Meyerhardt J, Wu K, et al. Circulating 25-hydroxyvitamin D levels and survival in patients with colorectal cancer. J Clin Oncol. 2008;26:2984-2991.
92. Giovannucci E. The epidemiology of vitamin D and cancer risk. In: Holick M, ed. Vitamin D: Physiology, Molecular Biology, and Clinical Applications. 2nd ed. Boston, MA: Humana Press; 2010:777-796.
93. Garland CF, Gorham ED, Mohr SB, Garland FC. Vitamin D for cancer prevention: global perspective. Ann Epidemiol. 2009;19: 468-483.
94. Holick M. Vitamin D: a millennium perspective. J Cell Biochem. 2003;88:296-307.
95. DeLuca H. Overview of general physiologic features and functions of vitamin D. Am J Clin Nutr. 2004;80(suppl): 1689S-1696S.
96. Rachez C, Freedman LP. Mechanisms of gene regulation by vitamin D(3) receptor: a network of coactivator interactions. Gene. 2000;246:9-21.
97. Welsh J. Vitamin D and breast cancer: insights from animal models. Am J Clin Nutr. 2004;80(suppl):1721S-1724S.
98. Holick M. Sunlight and vitamin D for bone health and prevention of autoimmune diseases, cancers, and cardiovascular disease. Am J Clin Nutr. 2004;80(suppl):1678S-1688S.
99. Grant WB, Holick MF. Benefits and requirements of vitamin D for optimal health: a review. Altern Med Rev. 2005;10:94-111.
100. Krause R, Buhring M, Hopfenmuller W, Holick MF, Sharma AM. Ultraviolet B and blood pressure. Lancet. 1998; 352:709-710.
101. Rostand S. Ultraviolet light may contribute to geographic and racial blood pressure differences. Hypertension. 1997;30: 150-156.
102. Ullah MI, Uwaifo GI, Nicholas WC, Koch CA. Does vitamin D deficiency cause hypertension? Current evidence from clinical studies and potential mechanisms. Int J Endocrinol. 2010; 2010:579640.
103. Wang T, Pencina M, Booth S, et al. Vitamin D deficiency and risk of cardiovascular disease. J Am Heart Assoc. 2008;117: 503-511.
104. Skragg R. Seasonality of cardiovascular disease mortality and the possible protective effect of ultra-violet radiation. Int J Epidemiol. 2010;10:337-341.
105. Skragg R. Sunlight, vitamin D and cardiovascular disease. In: Crass M, Avioli L, eds. Calcium-Regulating Hormones and Cardiovascular Function. Boca Raton, FL: CRC Press; 1995:213-237.
106. Spencer FA, Goldberg RJ, Becker RC, Gore JM. Seasonal distribution of acute myocardial infarction in the second National Registry of Myocardial Infarction. J Am Coll Cardiol. 1998; 31:1226-1233.
107. Giovannucci E, Liu Y, Hollis BW, Rimm EB. 25-Hydroxyvitamin D and risk of myocardial infarction in men: a prospective study. Arch Intern Med. 2008;168:1174-1180.
108. Melamed ML, Michos ED, Post W, Astor B. 25-Hydroxyvitamin D levels and the risk of mortality in the general population. Arch Intern Med. 2008;168:1629-1637.
109. Dobnig H, Pilz S, Scharnagl H, et al. Independent association of low serum 25-hydroxyvitamin d and 1,25-dihydroxyvitamin d levels with all-cause and cardiovascular mortality. Arch Intern Med. 2008;168:1340-1349.
110. Hsia J, Heiss G, Ren H, et al. Calcium/vitamin D supplementation and cardiovascular events. Circulation. 2007;115:846-854.
111. Newmark HL, Heaney RP. Calcium, vitamin D, and risk reduction of colorectal cancer. Nutr Cancer. 2006;56:1-2.
112. Sowers MR, Wallace RB, Lemke JH. The association of intakes of vitamin D and calcium with blood pressure among women. Am J Clin Nutr. 1985;42:135-142.
113. Forman JP, Bischoff-Ferrari HA, Willett WC, Stampfer MJ, Curhan GC. Vitamin D intake and risk of incident hypertension: results from three large prospective cohort studies. Hypertension. 2005;46:676-682.
114. Forman JP, Giovannucci E, Holmes MD, et al. Plasma 25-hydroxyvitamin D levels and risk of incident hypertension. Hypertension. 2007;49:1063-1069.
115. Scragg R, Sowers M, Bell C. Serum 25-hydroxyvitamin D, ethnicity, and blood pressure in the Third National Health and Nutrition Examination Survey. Am J Hypertens. 2007;20: 713-719.
116. Lewington S, Clarke R, Qizilbash N, Peto R, Collins R. Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies. Lancet. 2002;360:1903-1913.
117. Jorde R, Bonaa K. Calcium from dairy products, vitamin D intake, and blood pressure: the Tromso study. Am J Clin Nutr. 2000;71:1530-1535.
118. Poskitt EM, Cole TJ, Lawson DE. Diet, sunlight, and 25-hydroxy vitamin D in healthy children and adults. Br Med J. 1979;1:221-223.
119. Fahrleitner A, Dobnig H, Obernosterer A, et al. Vitamin D deficiency and secondary hyperparathyroidism are common complications in patients with peripheral arterial disease. J Gen Intern Med. 2002;17:663-669.
120. Margolis KL, Ray RM, Van Horn L, et al. Effect of calcium and vitamin D supplementation on blood pressure: the Women's Health Initiative Randomized Trial. Hypertension. 2008;52: 847-855.
121. Orwoll ES, Oviatt S. Relationship of mineral metabolism and long-term calcium and cholecalciferol supplementation to blood pressure in normotensive men. Am J Clin Nutr. 1990;52: 717-721.
122. Scragg R, Khaw KT, Murphy S. Effect of winter oral vitamin D3 supplementation on cardiovascular risk factors in elderly adults. Eur J Clin Nutr. 1995;49:640-646.
123. Li YC. Vitamin D regulation of the renin-angiotensin system. J Cell Biochem. 2003;88:327-331.
124. Loftus IM, Thompson MM. The role of matrix metalloprotei-nases in vascular disease. Vasc Med. 2002;7:117-133.
125. Perlstein TS, Lee RT. Smoking, metalloproteinases, and vascular disease. Arterioscler Thromb Vasc Biol. 2006;26: 250-256.
126. Timms PM, Mannan N, Hitman GA, et al. Circulating MMP9, vitamin D and variation in the TIMP-1 response with VDR genotype: mechanisms for inflammatory damage in chronic disorders? QJM. 2002;95:787-796.
127. Epstein FH, Ross R. Atherosclerosis: an inflammatory disease. N Engl J Med. 1999;340:115-126.
128. Daxecker H, Raab M, Markovic S, Karimi A, Griesmacher A, Mueller MM. Endothelial adhesion molecule expression in an in vitro model of inflammation. Clin Chim Acta. 2002;325: 171-175.
129. Visser M, Bouter LM, McQuillan GM, Wener MH, Harris TB. Elevated C-reactive protein levels in overweight and obese adults. JAMA. 1999;282:2131-2135.
130. Chen S, Sims GP, Chen XX, Gu YY, Chen S, Lipsky PE. Modulatory effects of 1,25-dihydroxyvitamin D3 on human B cell differentiation. J Immunol. 2007;179:1634-1647.
131. Rigby WF, Stacy T, Fanger MW. Inhibition of T lymphocyte mitogenesis by 1,25-dihydroxyvitamin D3 (calcitriol). J Clin Invest. 1984;74:1451-1455.
132. Daniel C, Sartory NA, Zahn N, Radeke HH, Stein JM. Immune modulatory treatment of trinitrobenzene sulfonic acid colitis with calcitriol is associated with a change of a T helper (Th) 1/Th17 to a Th2 and regulatory T cell profile. J Pharmacol Exp Ther. 2008;324:23-33.
133. Adorini L. Intervention in autoimmunity: the potential of vitamin D receptor agonists. Cell Immunol. 2005;233:115-124.
134. DeLuca HF, Cantorna MT. Vitamin D: its role and uses in immunology. FASEB J. 2001;15:2579-2585.
135. Scragg R, Sowers MF, Bell C. Serum 25-hydroxy vitamin D, diabetes, and ethnicity in the Third National Health and Nutrition Examination Survey. Diabetes Cure. 2004;27: 2813-2818.
136. Hypponen E, Laara E, Reunanen A, Jarvelin MR, Virtanen SM. Intake of vitamin D and risk of type 1 diabetes: a birth-cohort study. Lancet. 2001;358:1500-1503.
137. Hernan MA, Olek MJ, Ascherio A. Geographic variation of MS incidence in two prospective studies of US women. Neurology. 1999;53:1711-1718.
138. Leibowitz R, Davi S, Alter M. Geographical considerations in multiple sclerosis. Brain. 1967;90:871-886.
139. Ponsonby AL, McMichael A, van der Mei I. Ultraviolet radiation and autoimmune disease: insights from epidemiological research. Toxicology. 2002;181-182:71-78.
140. Embry AF, Snowdon LR, Vieth R. Vitamin D and seasonal fluctuations of gadolinium-enhancing magnetic resonance imaging lesions in multiple sclerosis. Ann Neurol. 2000;48:271-272.
141. Moum B, Aadland E, Ekbom A, Vatn MH. Seasonal variations in the onset of ulcerative colitis. Gut. 1996;38:376-378.
142. Leslie WD, Miller N, Rogala L, Bernstein CN. Vitamin D status and bone density in recently diagnosed inflammatory bowel disease: the Manitoba IBD Cohort Study. Am J Gastro-enterol. 2008;103:1451-1459.
143. Pappa HM, Gordon CM, Saslowsky TM, et al. Vitamin D status in children and young adults with inflammatory bowel disease. Pediatrics. 2006;118:1950-1961.
144. Staples JA, Ponsonby AL, Lim LLY, McMichael AJ. Ecologic analysis of some immune-related disorders, including type 1 diabetes, in Australia: latitude, regional ultraviolet radiation, and disease prevalence. Environ Health Perspect. 2003;111:518-523.
145. Oelzner P, Franke S, Muller A, Hein G, Stein G. Relationship between soluble markers of immune activation and bone turnover in post-menopausal women with rheumatoid arthritis. Rheumatology (Oxford). 1999;38:841-847.
146. Iikuni N, Nakajima A, Inoue E, et al. What's in season for rheumatoid arthritis patients? Seasonal fluctuations in disease activity. Rheumatology (Oxford). 2007;46:846-848.
147. Oelzner P, Muller A, Deschner F, et al. Relationship between disease activity and serum levels of vitamin D metabolites and PTH in rheumatoid arthritis. Calcif Tissue Int. 1998;62:193-198.
148. Barnes TC, Bucknall RC. Vitamin D deficiency in a patient with systemic lupus erythematosus. Rheumatology (Oxford). 2004; 43:393-394.
149. Huisman AM, White KP, Algra A, et al. Vitamin D levels in women with systemic lupus erythematosus and fibromyalgia. J Rheumatol. 2001;28:2535-2539.
150. Muller K, Kriegbaum NJ, Baslund B, Sorensen OH, Thymann M, Bentzen K. Vitamin D3 metabolism in patients with rheumatic diseases: low serum levels of 25-hydroxyvitamin D3 in patients with systemic lupus erythemato-sus. Clin Rheumatol. 1995;14:397-400.
151. Casteels K, Waer M, Bouillon R, et al. 1,25-Dihydroxyvitamin D3 restores sensitivity to cyclophosphamide-induced apoptosis in non-obese diabetic (NOD) mice and protects against diabetes. Clin Exp Immunol. 1998;112:181-187.
152. Mathieu C, Waer M, Laureys J, Rutgeerts O, Bouillon R. Prevention of autoimmune diabetes in NOD mice by 1,25-dihydroxyvitamin D3. Diabetologia. 1994;37:552-558.
153. Munger KL, Zhang SM, O'Reilly E, et al. Vitamin D intake and incidence of multiple sclerosis. Neurology. 2004;62:60-65.
154. Burton JM, Kimball S, Vieth R, et al. A phase I/II dose-escalation trial of vitamin D3 and calcium in multiple sclerosis. Neurology. 2010;74:1852-1859.
155. Mahon BD, Gordon SA, Cruz J, Cosman F, Cantorna MT. Cytokine profile in patients with multiple sclerosis following vitamin D supplementation. J Neuroimmunol. 2003;134: 128-132.
156. Carrieri PB, Provitera V, De RT, Tartaglia G, Gorga F, Perrella O. Profile of cerebrospinal fluid and serum cytokines in patients with relapsing-remitting multiple sclerosis: a correlation with clinical activity. Immunopharmacol Immunotoxicol. 1998;20:373-382.
157. Losy J, Michalowska-Wender G. In vivo effect of interferon-beta 1a on interleukin-12 and TGF-beta(1) cytokines in patients with relapsing-remitting multiple sclerosis. Acta Neurol Scand. 2002;106:44-46.
158. Liu P, Hewison M, Adams J. Vitamin D and the innate immunity. In: Holick M, ed. Vitamin D: Physiology, Molecular Biology, and Clinical Applications. 2nd ed. Boston, MA: Humana Press; 2010:297-310.
159. Medzhitov R. Recognition of microorganisms and activation of the immune response. Nature. 2007;449:819-826.
160. Sadeghi K, Wessner B, Laggner U, et al. Vitamin D3 down-regulates monocyte TLR expression and triggers hyporespon-siveness to pathogen-associated molecular patterns. Eur J Immunol. 2006;36:361-370.
161. Adams JS, Hewison M. Unexpected actions of vitamin D: new perspectives on the regulation of innate and adaptive immunity. Nat Clin Pract Endocrinol Metab. 2008;4:80-90.
162. Liu PT, Stenger S, Li H, et al. Toll-like receptor triggering of a vitamin D-mediated human antimicrobial response. Science. 2006;311:1770-1773.
163. Liu PT, Stenger S, Tang DH, Modlin RL. Cutting edge: vitamin D-mediated human antimicrobial activity against mycobacter-ium tuberculosis is dependent on the induction of cathelicidin. J Immunol. 2007;179:2060-2063.
164. Krutzik SR, Hewison M, Liu PT, et al. IL-15 links TLR2/1-induced macrophage differentiation to the vitamin D-dependent antimicrobial pathway. J Immunol. 2008;181:7115-7120.
165. Liu PT, Schenk M, Walker VP, et al. Convergence of IL-1beta and VDR activation pathways in human TLR2/1-induced antimicrobial responses. PLoS One. 2009;4:e5810.
166. Adams JS, Ren S, Liu PT, et al. Vitamin D-directed rheostatic regulation of monocyte antibacterial responses. J Immunol. 2009;182:4289-4295.
167. Zanetti M. Cathelicidins, multifunctional peptides of the innate immunity. J Leukoc Biol. 2004;75:39-48.
168. Golec M. Cathelicidin LL-37: LPS-neutralizing, pleiotropic pep-tide. Ann Agric Environ Med. 2007;14:1-4.
169. Schauber J, Dorschner RA, Coda AB, et al. Injury enhances TLR2 function and antimicrobial peptide expression through a vitamin D-dependent mechanism. J Clin Invest. 2007;117: 803-811.
170. Wang TT, Nestel FP, Bourdeau V, et al. Cutting edge: 1,25-dihydroxyvitamin D3 is a direct inducer of antimicrobial peptide gene expression. J Immunol. 2004;173:2909-2912.
171. Liu N, Nguyen L, Chun RF, et al. Altered endocrine and auto-crine metabolism of vitamin D in a mouse model of gastrointestinal inflammation. Endocrinology. 2008;149:4799-4808.
172. Hansdottir S, Monick MM, Hinde SL, Lovan N, Look DC, Hunninghake GW. Respiratory epithelial cells convert inactive vitamin D to its active form: potential effects on host defense. J Immunol. 2008;181:7090-7099.
173. Liu N, Kaplan AT, Low J, et al. Vitamin D induces innate antibacterial responses in human trophoblasts via an intracrine pathway. Biol Reprod. 2009;80:398-406.
174. Schauber J, Oda Y, Buchau AS, et al. Histone acetylation in ker-atinocytes enables control of the expression of cathelicidin and CD14 by 1,25-dihydroxyvitamin D3. J Invest Dermatol. 2008; 128:816-824.
175. Segaert S. Vitamin D regulation of cathelicidin in the skin: toward a renaissance of vitamin D in dermatology? J Invest Der-matol. 2008;128:773-775.
176. Peric M, Koglin S, Kim SM, et al. IL-17A enhances vitamin D3-induced expression of cathelicidin antimicrobial peptide in human keratinocytes. J Immunol. 2008;181:8504-8512.
177. Peric M, Koglin S, Dombrowski Y, et al. Vitamin D analogs differentially control antimicrobial peptide/"alarmin" expression in psoriasis. PLoS One. 2009;4:e6340.
178. Hewison M, Burke F, Evans KN, et al. Extra-renal 25-hydroxyvitamin D3-1alpha-hydroxylase in human health and disease. J Steroid Biochem Mol Biol. 2007;103:316-321.
179. Adams J, Sharma O, Gacad M, Singer F. Metabolism of 25-hydroxyvitamin D3 by cultured pulmonary alveolar macro-phages in sarcoidosis. J Clin Invest. 1983;72:1856-1860.
180. Bikle DD, Nemanic MK, Whitney JO, Elias PW. Neonatal human foreskin keratinocytes produce 1,25-dihydroxyvitamin D3. Biochemistry. 1986;25:1545-1548.
181. Roelandts R. The history of phototherapy: something new under the sun? J Am Acad Dermatol. 2002;46:926-930.
182. Ginde AA, Mansbach JM, Camargo CA Jr. Association between serum 25-hydroxyvitamin d level and upper respiratory tract infection in the third national health and nutrition examination survey. Arch Intern Med. 2009;169:384-390.
183. Wilkinson RJ, Llewelyn M, Toossi Z, et al. Influence of vitamin D deficiency and vitamin D receptor polymorphisms on tuberculosis among Gujarati Asians in west London: a case-control study. Lancet. 2000;355:618-621.
184. Gibney KB, MacGregor L, Leder K, et al. Vitamin D deficiency is associated with tuberculosis and latent tuberculosis infection in immigrants from sub-Saharan Africa. Clin Infect Dis. 2008; 46:443-446.
185. Hope-Simpson RE. The role of season in the epidemiology of influenza. J Hyg (Lond). 1981;86:35-47.
186. Hale A, Mattick K, Lewis D, et al. Distinct epidemiological patterns of Norwalk-like virus infection. J Med Virol. 2000;62: 99-103.
187. Putzker M, Sauer H, Kirchner G, Keksel O, Malic A. Community acquired diarrhea-the incidence of astrovirus infections in Germany. Clin Lab. 2000;46:269-273.
188. Suzuki H, Sakai T, Tanabe N, Okabe N. Peak rotavirus activity shifted from winter to early spring in Japan. Pediatr Infect Dis J. 2005;24:257-260.
189. Armas L. Vitamin D, infections and immune-mediated diseases. Int J Clin Rheumatol. 2009;4:89-103.
190. Canals M. Seasonal patterns of infectious disease: similarity and differences. Rev Med Chil. 1997;125:403-408.
191. Colizza V, Barrat A, Barthelemy M, Valleron AJ, Vespignani A. Modeling the worldwide spread of pandemic influenza: baseline case and containment interventions. PLoS Med. 2007;4:e13.
192. Sabetta JR, DePetrillo P, Cipriani RJ, Smardin J, Burns LA, Landry ML. Serum 25-hydroxyvitamin D and the incidence of acute viral respiratory tract infections in healthy adults. PLoS One. 2010;5:e11088.
193. Nursyam EW, Amin Z, Rumende CM. The effect of vitamin D as supplementary treatment in patients with moderately advanced pulmonary tuberculous lesion. Acta Med Indones. 2006;38:3-5.
194. Aloia JF, Li-Ng M. Re: epidemic influenza and vitamin D. Epidemiol Infect. 2007;135:1095-1096.
195. Laaksi I, Ruohola JP, Mattila V, Auvinen A, Ylikomi T, Pihlajamaki H. Vitamin D supplementation for the prevention of acute respiratory tract infection: a randomized, double-blinded trial among young Finnish men. J Infect Dis. 2010;202:809-814.